X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Prime Securities with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PRIME SECURITIES vs INDOCO REMEDIES - Comparison Results

PRIME SECURITIES    Change

Prime Securities is promoted by the Sheths which is also the controlling family of Great Eastern Shippng Company. The company offers financial services in the field of corporate finance, capital markets advisory, and broking. The company also establi... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PRIME SECURITIES INDOCO REMEDIES PRIME SECURITIES/
INDOCO REMEDIES
 
P/E (TTM) x 7.3 43.7 16.7% View Chart
P/BV x 171.6 2.8 6,213.2% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 PRIME SECURITIES   INDOCO REMEDIES
EQUITY SHARE DATA
    PRIME SECURITIES
Sep-13
INDOCO REMEDIES
Mar-17
PRIME SECURITIES/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs15360 4.2%   
Low Rs2249 0.8%   
Sales per share (Unadj.) Rs-12.1119.0 -10.2%  
Earnings per share (Unadj.) Rs-32.88.4 -391.7%  
Cash flow per share (Unadj.) Rs-32.515.2 -213.4%  
Dividends per share (Unadj.) Rs01.60 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs0.270.7 0.3%  
Shares outstanding (eoy) m26.4792.15 28.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x-0.72.6 -27.7%   
Avg P/E ratio x-0.336.4 -0.7%  
P/CF ratio (eoy) x-0.320.0 -1.3%  
Price / Book Value ratio x37.34.3 865.8%  
Dividend payout %019.1 0.0%   
Avg Mkt Cap Rs m22828,083 0.8%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m692,167 3.2%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m-32210,968 -2.9%  
Other income Rs m-3540 -87.7%   
Total revenues Rs m-35611,007 -3.2%   
Gross profit Rs m-6941,565 -44.4%  
Depreciation Rs m7633 1.1%   
Interest Rs m12862 206.6%   
Profit before tax Rs m-864909 -95.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3139 2.2%   
Profit after tax Rs m-867771 -112.5%  
Gross profit margin %215.914.3 1,513.4%  
Effective tax rate %-0.315.3 -2.3%   
Net profit margin %269.77.0 3,838.1%  
BALANCE SHEET DATA
Current assets Rs m1,9145,725 33.4%   
Current liabilities Rs m2,7955,454 51.2%   
Net working cap to sales %274.22.5 11,107.6%  
Current ratio x0.71.0 65.2%  
Inventory Days Days062 0.0%  
Debtors Days Days-1,46772 -2,044.5%  
Net fixed assets Rs m545,307 1.0%   
Share capital Rs m133184 72.1%   
"Free" reserves Rs m-1436,331 -2.3%   
Net worth Rs m66,516 0.1%   
Long term debt Rs m11,323 0.1%   
Total assets Rs m2,81711,970 23.5%  
Interest coverage x-5.715.6 -36.7%   
Debt to equity ratio x0.20.2 113.0%  
Sales to assets ratio x-0.10.9 -12.5%   
Return on assets %-26.27.0 -376.9%  
Return on equity %-14,214.811.8 -120,171.6%  
Return on capital %-9,810.712.4 -79,157.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m-404886 -45.6%  
From Investments Rs m393-1,706 -23.0%  
From Financial Activity Rs m-1961,316 -14.9%  
Net Cashflow Rs m-207497 -41.8%  

Share Holding

Indian Promoters % 0.0 59.2 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 12.5 1.6%  
FIIs % 1.9 6.0 31.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 98.0 22.4 437.5%  
Shareholders   25,229 12,805 197.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PRIME SECURITIES With:   INGERSOLL RAND  CHOLAMANDALAM INVEST.  CCL INTERNATIONAL  NALWA SONS INV  CREST VENTURES  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

ICICI Securities IPO: Will the Brokerage Shine If Markets Don't? (IPO)

Mar 22, 2018

Is the IPO of one of India's first online brokerage firm, ICICI Securities, worth applying for?

Shriram Trans Fin: Expansion on Track Driven by Brisk Demand and Strong Earnings (Quarterly Results Update - Detailed)

Feb 16, 2018

Shriram Transport Finance puts up a strong performance on robust demand and falling credit costs.

HDFC: Listing Gains Mask Healthy Growth and Asset Quality (Quarterly Results Update - Detailed)

Feb 7, 2018

Windfall listing gains utilised to shore up provisions and strengthen balance sheet further.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PRIME SECURITIES SHARE PRICE


Jun 22, 2018 (Close)

TRACK PRIME SECURITIES

  • Track your investment in PRIME SECURITIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PRIME SECURITIES

PRIME SECURITIES - NALWA SONS INV COMPARISON

COMPARE PRIME SECURITIES WITH

MARKET STATS